✦ LIBER ✦

Histone deacetylase inhibitors in clinical development

✍ Scribed by Rosato, Roberto R; Grant, Steven

Book ID: 127368069
Publisher: Informa plc
Year: 2004
Tongue: English
Weight: 317 KB
Volume: 13
Category: Article
ISSN: 1354-3784
DOI: 10.1517/13543784.13.1.21

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New clinical developments in histone dea

New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer

✍ Shundong Cang; Yuehua Ma; Delong Liu 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 309 KB

Application of Hematological Toxicity Mo

Application of Hematological Toxicity Modeling in Clinical Development of Abexinostat (S-78454, PCI-24781), A New Histone Deacetylase Inhibitor

✍ Quentin Chalret du Rieu, Sylvain Fouliard, Anne Jacquet-Bescond… 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 502 KB

253 Clinical development of histone deac

253 Clinical development of histone deacetylase inhibitors

✍ V. Richon 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 141 KB

CLINICAL DEVELOPMENT OF HISTONE DEACETYL

CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTS*

✍ Drummond, Daryl C.; Noble, Charles O.; Kirpotin, Dmitri B.; Guo, Zexiong; Scott, 📂 Article 📅 2005 🏛 Annual Reviews 🌐 English ⚖ 517 KB

Strategies in developing promising histo

Strategies in developing promising histone deacetylase inhibitors

✍ Lei Zhang; Hao Fang; Wenfang Xu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB

## Abstract Histone deacetylases (HDACs) are a family of enzymes that have been of interest in drug discovery for more than 30 years. Inhibitors of HDACs are potential therapeutics for various diseases, such as neurodegenerative diseases, inflammation, viral infection, and especially cancer. Most H

Histone Deacetylase Inhibitors

✍ Thomas A. Miller; David J. Witter; Sandro Belvedere 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 53 KB